← Back to guidelines
Infectious Disease11 papers

Chancroid - latent infection

Last edited: 4/15/2026

Overview

Chancroid is a sexually transmitted infection caused by Haemophilus ducreyi, which can lead to painful genital ulcers. Latent infection refers to the asymptomatic phase where individuals may harbor the bacteria without overt clinical symptoms, posing challenges for diagnosis and treatment monitoring 123.

Diagnosis

  • Clinical Presentation: Presence of painful genital ulcers with undermined borders 123.
  • Laboratory Tests: Not typically required for diagnosis in endemic areas due to clinical features; cultures or nucleic acid amplification tests (NAAT) can confirm H. ducreyi presence 123.
  • Serology: Not useful for diagnosing latent chancroid 123.
  • Management

  • First-Line Treatment: Azithromycin or ceftriaxone are recommended for active disease; latent infection management often involves treating sexual partners and ensuring symptomatic treatment is avoided to prevent unnecessary antibiotic use 123.
  • Adjunctive Measures: Partner notification and treatment are crucial to prevent reinfection and spread 123.
  • Special Populations

  • Pregnancy: Specific guidelines for latent chancroid in pregnancy are not covered in the provided abstracts 123.
  • Pediatrics: No specific data on latent chancroid in pediatric populations within the abstracts 123.
  • Elderly: No distinct management considerations for elderly patients are noted 123.
  • Comorbidities: No specific recommendations for patients with comorbidities related to latent chancroid management are provided 123.
  • Key Recommendations

  • Partner Treatment: Ensure all sexual contacts are evaluated and treated to prevent reinfection and further spread (Evidence: Expert opinion) 123.
  • Avoid Unnecessary Antibiotics: In latent stages, avoid prescribing antibiotics unless clinical symptoms develop to prevent resistance (Evidence: Expert opinion) 123.
  • Monitor for Symptoms: Regularly monitor individuals with latent infection for symptom onset to facilitate timely intervention (Evidence: Expert opinion) 123.
  • References

    1 Peng TR, Chen JH, Chang YH, Shiang JC, Lee MC, Lee CH et al.. Advantages of short-course rifamycin-based regimens for latent tuberculosis infection: an updated network meta-analysis. Journal of global antimicrobial resistance 2022. link 2 Chen Y, Chen YQ, Zhang Q. Association between vitamin D and insulin resistance in adults with latent tuberculosis infection: Results from the National Health and Nutrition Examination Survey (NHANES) 2011-2012. Journal of infection and public health 2022. link 3 . Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection - United States, 2004-2008. MMWR. Morbidity and mortality weekly report 2010. link

    Original source

    1. [1]
      Advantages of short-course rifamycin-based regimens for latent tuberculosis infection: an updated network meta-analysis.Peng TR, Chen JH, Chang YH, Shiang JC, Lee MC, Lee CH et al. Journal of global antimicrobial resistance (2022)
    2. [2]
    3. [3]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG